talipexole has been researched along with Idiopathic Parkinson Disease in 9 studies
talipexole: dopamine receptor agonist; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report sinus bradycardia induced by talipexole hydrochloride in a 65-year-old man with Parkinson disease." | 7.70 | [Sinus bradycardia induced by talipexole hydrochloride in a patient with Parkinson disease]. ( Ii, Y; Kuzuhara, S; Sakai, T, 1998) |
| "We report sinus bradycardia induced by talipexole hydrochloride in a 65-year-old man with Parkinson disease." | 3.70 | [Sinus bradycardia induced by talipexole hydrochloride in a patient with Parkinson disease]. ( Ii, Y; Kuzuhara, S; Sakai, T, 1998) |
| "Talipexole hydrochloride has been on market in Japan recently, but MAO-B inhibitors and COMT inhibitors are in final stages to wait evaluations by the governmental committee." | 2.40 | [Clinical characteristics and trends in research of Parkinson's disease and parkinsonism in Japan]. ( Yanagisawa, N, 1997) |
| " The dosage of talipexole was gradually reduced and the drug was ultimately discontinued since incomplete neuroleptic malignant syndrome was suspected." | 1.31 | [Increase in serum creatine phosphokinase following administration of talipexole hydrochloride]. ( Imai, T; Osumi, E, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamigaichi, R | 1 |
| Kubo, S | 1 |
| Ishikawa, K | 1 |
| Yokoyama, K | 1 |
| Ogaki, K | 1 |
| Usui, C | 1 |
| Hatta, K | 1 |
| Arai, H | 1 |
| Mochizuki, H | 2 |
| Hattori, N | 2 |
| Kitamura, Y | 2 |
| Yamashiro, K | 1 |
| Komine-Kobayashi, M | 1 |
| Hatano, T | 1 |
| Urabe, T | 1 |
| Iwama, Y | 1 |
| Daida, H | 1 |
| Sakai, M | 1 |
| Nakayama, T | 1 |
| Mizuno, Y | 1 |
| Yanagisawa, N | 1 |
| Kakimura, J | 1 |
| Taniguchi, T | 1 |
| Sakai, T | 1 |
| Ii, Y | 1 |
| Kuzuhara, S | 1 |
| Osumi, E | 1 |
| Imai, T | 1 |
| Herschel, M | 1 |
| Hinzen, D | 1 |
| Hornykiewicz, O | 1 |
| Kobinger, W | 1 |
| Pichler, L | 1 |
| Pifl, C | 1 |
| Schingnitz, G | 1 |
2 reviews available for talipexole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
[Dopaminergic neuroprotection and reconstruction of neural network tiara].
Topics: Animals; Azepines; Benzothiazoles; Brain; Dopamine; Dopamine Agonists; Embryonic Stem Cells; Humans; | 2010 |
[Clinical characteristics and trends in research of Parkinson's disease and parkinsonism in Japan].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azepines; Child; Child, Preschool; Disease Progression; | 1997 |
7 other studies available for talipexole and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report.
Topics: Aged; Antiparkinson Agents; Azepines; Benzothiazoles; Cabergoline; Carbidopa; Catatonia; Catechols; | 2009 |
The frequency of cardiac valvular regurgitation in Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Ago | 2008 |
Protective effect of talipexole on MPTP-treated planarian, a unique parkinsonian worm model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Azepines; Brain; Disease Models, Animal; Dopa | 1998 |
[Sinus bradycardia induced by talipexole hydrochloride in a patient with Parkinson disease].
Topics: Acute Disease; Aged; Arrhythmia, Sinus; Azepines; Bradycardia; Dopamine Agonists; Humans; Male; Park | 1998 |
[Increase in serum creatine phosphokinase following administration of talipexole hydrochloride].
Topics: Azepines; Creatine Kinase; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndr | 2000 |
[The dopamine receptor. Target of various diseases].
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Brain; Humans; Macaca mulatta; Parkinson Disease; Prol | 1987 |
The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
Topics: Animals; Azepines; Brain Chemistry; Drug Interactions; Ibotenic Acid; Macaca mulatta; Male; Mice; Mi | 1986 |